Skip to content

Addiction: all studies

Page 433 of 857: studies 4,321 to 4,330 of 8,563, newest first. Back to the addiction overview

Research

Therapeutic potential of N,N-dimethyltryptamine in the treatment of psychiatric and neurodegenerative disorders

Pharmacotherapy in Psychiatry and Neurology 2023 Jakub Schimmelpfennig, Kamila Jankowiak-Siuda

AMA Schimmelpfennig J, Jankowiak-Siuda K. Therapeutic potential of N,N-dimethyltryptamine in the treatment of psychiatric and neurodegenerative disorders. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii. 2023;39(2):115-130. doi:10.5114/fpn.2023.131979. APA Schimmelpfennig, J., & Jankowiak-Siuda, K. (2023). Therapeutic potential of N,N-dimethyltryptamine in...

Translational research investigating psilocybin

2023 Manon M.j. van den Berg

This dissertation has taken an interdisciplinary approach to investigate and give insights into psilocybin’s neurobiological underpinnings. Psilocybin is a naturally occurring serotonergic psychedelic and is the main ingredient in hallucinogenic mushrooms. Research has demonstrated that psilocybin profoundly activates the serotonin (5-hydroxytryptamine) 2A (5-HT2A) receptors. Upon activation of...

Psychedelic-Assisted Therapy and Meditative Experience as Factors of Personal Change

Bulletin of Taras Shevchenko National University of Kyiv Psychology 2023 Nadiia Omelchenko, Anton Kurapov 1 citation

Background. As a result of the military attack in Ukraine, both the military and civilian population are facing mental health disorders such as post-traumatic stress disorder (PTSD), depression, anxiety, and panic attacks. Classical psychotherapy and psychiatry are often ineffective in treating these conditions. In the United States and Europe, a significant amount of research is being...

Psilocybin in the treatment of generalized anxiety disorder (GAD), alcoholism and smoking: a literature review

IJS - International Journal of Sciences 2023 Fabiano F. Da Silva, Thaysa Adriane Costa Bernardo, Johny Ricarte Das Silva Rodrigues et al. 1 citation

Psilocybin in the treatment of generalized anxiety disorder has become a strong point since it can have important benefits in the treatment. The general objective of the present study is to review the literature on the use of psilocybin in the treatment of generalized anxiety disorder (GAD), alcoholism and smoking, in order to compile and analyze the available evidence on its efficacy, safety...

Contextual Parameters Associated with Positive and Negative Mental Health in Recreational Psychedelic Users.

Journal of Psychoactive Drugs 2023 Kevin O. St. Arnaud, Donald Sharpe 31 citations

Growing research exploring the utility of psychedelic substances suggests that they not only hold promise for clinical practice but may enhance mental health through recreational use as well. However, given the importance of set and setting for maximizing benefits and minimizing harms of drug use, it is important to develop a foundational understanding of the contextual factors associated with...

DOI: 10.1080/02791072.2022.2039815 (opens in new tab) Full text (opens in new tab) Psychedelics Drug policy Entheogens Harm reduction +2

Designing voice interfaces to support mindfulness-based pain management.

Digital health 2023 Sanjana Mendu, Sebrina L Doyle Fosco, Stephanie T. Lanza et al. 5 citations

Chronic pain is a critical public health issue affecting approximately 20% of the adult population in the United States. Given the opioid crisis, there has been an urgent focus on non-addictive pain management methods including mindfulness-based stress reduction (MBSR). Prior work has successfully used MBSR for pain management. However, ensuring longitudinal engagement in MBSR practices remains...

DOI: 10.1177/20552076231204418 (opens in new tab) Full text (opens in new tab) Mindfulness-based stress reduction Chronic pain Smart speaker Voice interface

Interventions combining mindfulness training with non-invasive brain stimulation and their impact on mental health outcomes: Protocol for a systematic review and meta-analysis of randomized controlled trials.

PLoS One 2023 Anastasia Demina, Benjamin Petit, Vincent Meille et al. 2 citations

Mindfulness training programs and non-invasive brain stimulation are both evidence-based interventions that have applications in mental health disorders. While both have showed promising results on a range of symptoms related to mental health, their combination has more recently grabbed the attention of researchers. There is a theoretical framework for their synergistic effects, and these...

When philosophical nuance matters: safeguarding consciousness research from restrictive assumptions.

Frontiers in Psychology 2023 Marius Usher, Niccolò Negro, Hilla Jacobson et al. 7 citations

In this paper, we revisit the debate surrounding the Unfolding Argument (UA) against causal structure theories of consciousness (as well as the hard-criteria research program it prescribes), using it as a platform for discussing theoretical and methodological issues in consciousness research. Causal structure theories assert that consciousness depends on a particular causal structure of the...

Challenges and considerations for treating PTSD with medicinal cannabis: the Australian clinician's perspective.

Expert Review of Clinical Pharmacology 2023 Luke J. Ney, Wole Akosile, Chris Davey et al. 8 citations

Preclinical and experimental research have provided promising evidence that medicinal cannabis may be efficacious in the treatment of posttraumatic stress disorder (PTSD). However, implementation of medicinal cannabis into routine clinical therapies may not be straightforward. In this review, we describe some of the clinical, practical, and safety challenges that must be addressed for...

DOI: 10.1080/17512433.2023.2276309 (opens in new tab) Full text (opens in new tab) Cannabis Clinical medicine Exposure therapy Posttraumatic stress disorder